SEMA3C and head and neck squamous cell carcinoma: Chen [22] and Zhang et al.  [23] found that SEMA3C shows worse disease‐free survival with higher expression and is up‐regulated in clinical samples of head and neck squamous cell carcinoma (HNSCC).